Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Completed

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

NCT01401959

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations: Florida Cancer Specialists North Fort Myers, Florida, United States

Florida Cancer Specialists South Fort Myers, Florida, United States

Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States

Florida Hospital Cancer Insitute Orlando, Florida, United States

View all 18 locations

View Trial Details

Completed

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

NCT03491033

Conditions: Advanced-stage Ovarian Cancer, Neoplasm, Residual, Neoplasms, +3 more
Locations: Severance hospital Seoul, South Korea

View Trial Details

Completed

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

NCT01347996

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Sahlgrenska Academy, University of Gothenburg Gothenburg, Sweden

View Trial Details

Completed

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

NCT02339805

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Centre Henri Becquerel Rouen, France

View Trial Details

Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

NCT00816049

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Department of Pediatrics, Rigshospitalet Copenhagen, Denmark

Helsinki University Hospital Helsinki, Finland

University Hospital Reykjavik, Iceland

Trondheim University Hospital Trondheim, Norway

View Trial Details

Completed

Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy

NCT03054883

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Not specified

View Trial Details

Completed

Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer

NCT02980185

Conditions: Disease-Free Survival, Neoplasm, Residual, Neoplasms, +5 more
Locations: Department of Obstetrics and Gynecology Universita' Dell'Insubria Varese, Italy

View Trial Details

Completed

Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer

NCT02900950

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
Locations: S.Orsola-Malpighi Hospital, University of Bologna Bologna, Italy

View Trial Details

Completed

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

NCT02714790

Conditions: Acute Myeloid Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

LAL-BR/2001: Study Treatment to Low Risk ALL

NCT00526175

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital Valle Hebrón-Materno Infantil Barcelona, Spain

Complejo Hospitalario Reina Sofía Córdoba, Spain

Hospital Clínico San Carlos de Madrid Madrid, Spain

View all 25 locations

View Trial Details